GEN (Genetic Engineering & Biotechnology News)

Recent stories from GEN (Genetic Engineering & Biotechnology News).

GEN (Genetic Engineering & Biotechnology News) Uduak Thomas

Former Verily Leaders Build AI Platform to Get More from Proteomics Data

Tesorai’s AI platform reanalyzes massive proteomics repositories, letting researchers mine raw mass spectrometry data instead of condensed forms. In an Alzheimer’s project, it found phosphorylated tau 217 in four datasets where the original authors did not report it.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

Type 1 Diabetes Delayed in Mice by Stem Cell-Derived Vesicles That Calm Immune Response

Extracellular vesicles produced by certain types of pluripotent stem cells (PSC) were found to help reduce immune attacks on insulin-producing cells in the pancreas and delay the onset of diabetes in a mouse model.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

Alzheimer’s Disease and Aging Linked to Changes in the Hypothalamus

Researchers combined measurements from brain images and single cell transcriptome maps to build a resource, HypoAD, as an atlas of the human hypothalamus in aging and AD, which they have made available to the research community.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

CRISPR Screening Reveals How Genetic Variants Drive Neurodegenerative Risk

Researchers studying human induced pluripotent stem cell-derived microglia-like cells showed how genetic variants can impact cell behavior and used CRISPR gene editing to show how one gene’s effect depends on its cellular context.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Julianna LeMieux, PhD

Targeting Folate Receptor Reverses Colorectal Cancer’s Resistance to Immunotherapy in Mice

Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in colorectal cancer, overcoming immune evasion in mouse models.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Alex Philippidis

London Calling: Flagship Expands in U.K. to Build AI-Native Platform Companies

Flagship expects to recruit and train an initial team of approximately 50 U.K.-based scientist-entrepreneurs and operators for the new Origination Lab, U.K., which will build on three years of experience partnering and conducting R&D across the kingdom.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

The Advent of Automated, Gene-Engineered TIL Manufacturing

Automating engineered TIL manufacturing in a way that maintains their tumor-fighting capabilities may move this emerging therapeutic class into a commercially reproducible, economically viable therapeutic option.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

Tuning Extracellular Vesicle Production and Analytics for Compliance

The complexity of extracellular vesicle products developed from umbilical cord blood can potentially be reduced through production processes and simplified quality control strategies, helping to boost this new product class.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

One Record, From Factory Floor to Patient

ParkourSC acquired manufacturing-AI company Quartic to track a drug’s quality across its whole lifecycle. CEO Mahesh Veerina explains how linking factory and shipping data could flag at-risk batches before problems reach patients.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

Growing Apart: Culture-Based Sterility Test Alternatives

Growth-based sterility testing works for traditional biopharma but is too slow for the cell therapy sector. A new parallel testing pathway and rapid, molecular assay-based testing are a better option.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Savannah Wiegel

Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice

In mice, alcohol cut the efficacy of anti-PD-1 immunotherapy by roughly 50%, suppressing tumor-infiltrating and memory T cells while boosting TIGIT-carrying ones. Blocking TIGIT restored the response.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Alex Philippidis

Beyond Amyloid and Tau: Alzheimer’s Drug Developer Sees Early Clinical Success for Immunotherapy-Based Approach

ImmunoBrain's approach contrasts with decades of conventional thinking among researchers, which held that Alzheimer’s was a disease of toxic proteins—an outgrowth of thinking that immune activity in the brain was in itself a sign of pathology.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

Genetic Barcoding Reveals How Pre-Bone Marrow Transplant Conditioning Impacts Immune System Regeneration

Researchers used genetic barcoding to track human blood-forming stem and progenitor cells transplanted into mice, revealing how the different cell types regenerate the blood and immune system, and how different forms of pretransplant conditioning affected blood and immune cell recovery.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Julianna LeMieux, PhD

Mapping the Hidden Viral Communities of the Human Gut Microbiome

Researchers identified over 116,000 gut viral groups, revealing previously unknown relationships between viruses, bacteria, and metabolism, with findings offering new insights into gut health and irritable bowel syndrome (IBS).

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Savannah Wiegel

Enhancer-Targeted CRISPR Turns Up Healthy Gene Copy in Autism Organoid Model

In lab-grown human neurons and organoids carrying CHD8 or SCN2A mutations, researchers reduced organoid overgrowth and moved neuronal electrical activity closer to wild-type levels.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Kathy Vuksanaj

Toward Connected Laboratory Ecosystems

In this GEN podcast, the third in a series, LabVantage’s Denise Bell discusses how laboratories can reduce operational fragmentation and build connected, scalable operations.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

Gut Microbome and Bile Acid Modification Linked with Longevity

Researchers studying how gut microbes modify bile acids have identified changes in the metabolic activity of the gut microbiome associated with exceptional longevity in humans, and found that amplifying the same activity with engineered bacteria improved metabolic health in aged mice.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Uduak Thomas

Single-Cell Method Reveals On- and Off-Target Effects of Cas9 Edits on Gene Expression

A new method called Superb-seq pairs Cas9 editing with single-cell RNA sequencing to show which edits, including off-target ones, occur in each cell and how they alter gene expression, offering a clearer view of genome editing’s potential consequences.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Alex Philippidis

StockWatch: Amid Nvidia Turmoil, What Happens to Its Life Sciences Collaborations?

While Nvidia doesn’t develop new therapies, instruments, or reagents, its AI technology powers numerous collaborations with biopharma and lab tools giants stretching back at least five years.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

DCIS Cell Atlas Reveals Clues to Invasive Breast Cancer Progression

Researchers created a detailed map of the tumor microenvironment surrounding estrogen receptor-positive ductal carcinoma in situ, which may help better predict progression to invasive breast cancer and inform on future therapeutic strategies.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Julianna LeMieux, PhD

How Vancomycin-Resistant Enterococcus Evolved in a Danish Hospital

A genomic study reveals how genetic mutations, recombination, and resistance-carrying plasmids shaped the evolution, diversification, and decline of vancomycin-resistant Enterococcus faecium in Danish hospitals between 2012 and 2020.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Kathy Vuksanaj

Downstream Processing: Purifying Complex Antibody Therapeutics When Target Molecules Misbehave

In this GEN webinar, downstream process development and scale up manufacturing specialists will discuss practical strategies for building robust purification processes when the target molecule misbehaves.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Savannah Wiegel

Reference Genomes of Malaria-Causing Plasmodium Parasites Completed

Using DNA sequenced from patient blood samples, researchers assembled complete reference genomes of neglected malaria parasites, uncovering genetic regions potentially involved in immune evasion and providing new tools for disease surveillance.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

High Frequency of Drug-Impacting Gene Variants Found in All of Us Cohort

A study finds that everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Uduak Thomas

Neuroprotective Protein Atlas Positions the Blood-Brain Barrier as a Selective Checkpoint

The blood-brain barrier keeps most proteins in the bloodstream out of the brain, but not all. The pathways that import them are damaged early in Alzheimer’s disease models, hinting at new ways to treat the disease.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

How Breast Cancer Chemotherapy May Impact Biological Aging and Loss of Healthy Life Years

Chemotherapy helps many women survive breast cancer, but the results of new research suggest that chemotherapy may also accelerate biological aging beyond chronological age and increase the risk of earlier death from other causes.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

From Farm Waste to Medical Nanoparticles

Fruit peels, rice husks, and other crop leftovers can yield biomedical nanoparticles, but variable feedstocks, scale-up hurdles, and thin safety data still stand between lab promise and reliable commercial bioprocessing.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

Hybrid Model Captures Lactate Run-Away and Back-Metabolism

A hybrid model provides hard-to-achieve insights into lactate performance during bioprocessing, creating conditions for more accurate predictions to better manage key batch parameters and variability.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

Extracellular Vesicle Product Developer Creates Potency Assay

A company developing extracellular vesicle-based products has developed a potency assay for quality control. They hope to adapt it for future products and scale it to commercial manufacturing.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Corinna Singleman, PhD

Automation a Path to Lower Cell Therapy Costs

Australian developer Currus Bio predicts that automating the production of its candidate cancer cell therapy, CUR-001, using the Cocoon platform will reduce costs and enhance its ability to scale production as the product moves through trials.

Read at GEN (Genetic Engineering & Biotechnology News)

Older stories